accord
data
world
health
organi
zation
share
mortal
caus
infec
tiou
parasit
diseas
consider
decreas
approxim
fig
versu
moral
iti
cardiovascular
cancer
diseas
notic
increas
undoubtedli
expans
vaccin
develop
develop
countri
underli
decreas
infecti
parasit
di
eas
increas
cardiovascular
cancer
mortal
associ
increas
lifespan
peopl
began
attain
age
diseas
preval
increas
rate
remain
mortal
caus
con
sider
degre
sad
side
effect
caus
devel
opment
civil
name
increas
number
road
traffic
injuri
occup
acci
dent
casualti
figur
show
caus
mortal
russia
accord
goskomstat
state
statist
committe
russian
feder
share
cardiovascular
diseas
declin
year
well
technogen
mortal
homi
cide
suicid
wherea
share
cancer
di
eas
increas
similar
develop
countri
infec
tiou
diseas
mortal
caus
russia
fifth
list
howev
global
ratio
mortal
caus
gener
differ
russia
sinc
three
fourth
world
popul
live
devel
ope
undevelop
countri
mortal
infecti
diseas
still
high
one
sig
nific
differ
russia
sever
devel
ope
countri
name
cardiovascular
mortal
countri
consider
higher
compar
cancer
mortal
countri
japan
unit
state
norway
mortal
almost
equal
thu
mortal
caus
infecti
di
eas
countri
develop
vaccin
infect
proper
control
drink
water
qualiti
fifth
list
mortal
caus
versu
first
posit
countri
implement
measur
diagram
fig
show
caus
child
ga
trointestin
diseas
develop
countri
kapikian
evid
rotavirus
account
infect
astrovirus
cali
civirus
adenovirus
remain
infect
caus
bacteria
yet
unknown
pathogen
thu
virus
caus
gastrointestin
diseas
children
develop
countri
howev
intestin
infect
account
human
infecti
diseas
wherea
main
human
infect
caus
respiratori
diseas
begin
centuri
etiolog
caus
infect
investig
michi
gan
unit
state
monto
emerg
major
part
diseas
caus
rhinovi
ruse
fig
follow
coronavirus
influenza
viru
third
list
parainfluenza
re
piratori
syncyti
virus
fourth
follow
bac
teria
small
share
adenoviru
infect
group
undistinguish
infect
account
remain
note
influenza
third
place
sinc
respiratori
infect
vac
cine
avail
use
begin
centuri
human
metapneumovirus
discov
ere
character
pathogen
caus
respiratori
infect
kahn
hoogen
et
al
william
et
al
thu
like
unknown
infect
diagram
approxi
mate
determin
metapneumovirus
correspondingli
viral
pathogen
caus
respiratori
diseas
slightli
higher
share
compar
gastrointestin
diseas
torch
infect
danger
pregnant
women
fetu
torch
acronym
toxoplasmosi
agent
rubella
cytomegaloviru
herp
simplex
list
infect
current
com
prise
parvoviru
varicella
zoster
viru
vzv
west
nile
viru
measl
viru
enterovirus
adenovirus
human
immunodefici
viru
hiv
hepat
b
c
virus
hepat
e
viru
chlamydi
infect
syphili
gonococc
infect
listeriosi
lymphocyt
choriomening
viru
lcmv
small
rodent
host
emerg
teratogen
pathogen
human
presum
virus
bacteria
part
agent
caus
seem
ingli
safe
common
peopl
respiratori
ga
trointestin
diseas
torch
infect
specif
danger
fetu
pregnant
women
particular
parvoviru
attract
consider
attent
past
decad
pathogen
littl
known
common
popul
countri
viru
studi
refer
fifth
diseas
children
infec
tion
consider
danger
adult
children
year
old
danger
pregnant
women
fetu
caus
prenat
death
consequ
kapikian
pp
introduct
molecular
virolog
annual
four
case
record
past
year
case
men
like
men
pass
infect
anybodi
group
torch
infect
need
much
research
attent
sinc
contribut
pathogen
case
pregnanc
failur
russia
still
vagu
virus
classif
definit
term
viru
latin
mean
poison
sever
definit
viru
given
two
definit
viru
microscop
particl
compos
protein
nucleic
acid
frequent
lipid
lip
id
origin
host
cell
abl
infect
cell
live
organ
reproduc
cell
virus
obligatori
intracellular
organ
depriv
energi
gen
erat
protein
synthes
system
depend
famili
differ
set
ele
ment
requir
replic
transcript
system
first
definit
structur
second
one
function
like
latter
amend
sinc
giant
virus
discov
element
protein
synthes
energi
produc
system
moreov
scientist
awar
virus
exist
natur
bacteria
archaea
fungi
protozoan
plant
ani
mal
human
virus
oblig
depend
parasit
moreov
know
virus
artifici
construct
pc
phone
comput
phone
virus
correctli
refer
virus
sinc
act
host
manner
virus
live
organ
initi
classif
virus
develop
base
diseas
symptom
exampl
hepati
ti
later
base
similar
local
bodi
myxovirus
final
base
structur
virion
howev
attempt
unsuccess
current
classif
virus
base
similar
differ
gene
type
struc
ture
similar
major
gene
particular
similar
differ
polymeras
gene
sequenc
antigen
properti
major
surfac
protein
characterist
correl
genom
base
classif
terminolog
associ
viral
speci
gen
otyp
strain
isol
yet
establish
set
paper
specifi
definit
taxonom
unit
genu
speci
genotyp
serotyp
strain
isol
publish
bibl
virologist
involv
taxonom
issu
viru
taxonomi
monograph
publish
everi
year
last
edi
tion
issu
decemb
book
weigh
approxim
kg
compris
page
introduct
explain
approxim
one
third
virus
far
classifi
famili
order
need
done
research
viral
genom
may
consist
dna
rna
dna
virus
may
either
doubl
strand
singl
strand
dna
may
contain
lipid
env
lope
famili
human
dna
virus
indi
vidual
famili
virus
exploit
human
list
tabl
rna
virus
contain
one
uniqu
famili
famili
reovirus
genom
form
doubl
strand
rna
live
organ
genom
except
virus
remain
rna
virus
singl
strand
rna
genom
genom
rna
may
rna
genom
rna
also
messeng
rna
two
addit
viru
famili
mem
ber
follow
revers
transcript
mecha
nism
replic
name
hepadnavirus
hepadnavirida
dna
envel
ope
virus
circular
partial
doubl
strand
dna
revers
transcriptasedna
polymeras
encod
genom
retrovirus
retrovirida
rna
envelop
virus
revers
transcriptasedna
polymeras
encod
genom
hiv
virus
infect
repres
three
kingdomsarchaea
bacteria
eukaryadi
play
specif
featur
correspond
kingdom
suggest
emerg
earli
evolu
tion
life
follow
hypothes
origin
virus
current
discuss
virus
first
emerg
among
organ
ism
virus
degrad
variant
bacteria
virus
degrad
variant
cell
organellesmitochondria
other
virus
evolv
mobil
element
genom
accord
avail
indirect
data
scientist
believ
first
emerg
world
rna
wherea
world
dna
appear
much
later
like
rna
virus
emerg
earlier
follow
dna
virus
presum
virus
multipl
ori
gin
correspondingli
differ
hypothes
propos
variou
viru
order
famili
note
virus
carri
doubl
strand
rna
genom
reovirida
famili
like
ancient
structur
genom
virus
simplest
virus
carri
nucleocapsida
nucleic
acid
case
rna
fig
surround
capsid
c
proteinin
center
virion
viru
particl
membran
protein
built
lipid
membran
surround
nucleocapsid
spike
envelop
e
protein
insert
membran
outer
side
virion
tick
born
enceph
viru
compris
three
mention
protein
arrang
figur
show
genom
map
tick
born
enceph
viru
genom
region
encod
structur
protein
c
e
local
left
correspond
gene
follow
order
protein
arrang
viru
center
peripheri
first
c
protein
surround
rna
enclos
membran
incorporat
ing
protein
e
protein
gene
code
structur
protein
follow
gene
non
structur
protein
polymeras
proteas
helicas
unwind
rna
replic
sever
pro
tein
still
unknown
function
special
pat
tern
order
gene
far
detect
except
fact
polymeras
gene
viru
typic
last
one
research
molecular
biolog
virus
reveal
sever
new
viru
threat
chang
earlier
exist
threat
present
virus
annual
dynam
tick
born
enceph
tbe
morbid
differ
european
countri
shown
exampl
fig
pattern
consid
abli
differ
russia
sinc
correspond
ing
viru
exist
circul
long
time
wherea
compar
recent
start
spread
europ
tbe
pattern
switzerland
especi
illustr
tbe
case
record
swit
zerland
diseas
appear
preval
gradual
increas
current
howev
one
hand
emerg
genom
differ
exceed
siberian
genotyp
also
reach
europ
current
follow
type
threat
pre
sent
viru
infect
consid
emerg
reemerg
infect
emerg
infect
illustr
phylogenet
tree
genom
coronaviru
famili
fig
sar
coronaviru
caus
epidem
atyp
pneumonia
tree
also
contain
data
genom
coronavirus
isol
palm
civet
raccoon
dog
live
china
form
separ
branch
rel
human
virus
branch
anim
coronavirus
display
minor
differ
strain
recov
human
name
delet
nucleotid
one
gene
overal
genom
compris
nucleotid
ie
delet
account
genom
addit
two
mutat
discov
gene
human
virus
togeth
mention
delet
determin
pathogen
human
anoth
illustr
emerg
infect
latest
data
origin
hepat
c
viru
hcv
moment
viru
discov
assum
jump
human
monkey
howev
hepat
viru
isol
dog
display
high
homolog
human
hcv
kapoor
et
al
first
viru
detect
dog
name
canin
hepat
viru
chv
sinc
local
liver
five
dog
die
unknown
gastrointestin
diseas
examin
interestingli
chv
rna
amount
detect
respiratori
sampl
larger
compar
liver
sampl
bioinformat
analysi
chv
genom
demonstr
genet
closer
hcv
analog
monkey
virus
hcv
chv
like
common
ancestor
form
two
branch
approxim
year
ago
much
later
dog
domesti
cate
possibl
hepacivirus
mainli
canin
virus
human
hcv
emerg
via
select
chv
human
host
altern
scenario
exclud
hepacivirus
infect
mani
anim
speci
chain
event
could
revers
verif
hypothesi
requir
screen
anim
speci
hepa
civirus
relat
human
hcv
thu
molecular
genet
tool
allow
distribu
tion
rout
human
infect
detect
well
sometim
origin
erad
infect
infect
eradica
tion
track
type
viru
threat
relat
diseas
smallpox
poliomyel
measl
hepat
b
mump
known
humankind
success
erad
smallpox
sever
diseas
also
known
global
program
polio
eradica
tion
well
preparatori
activ
eradi
cation
measl
hepat
b
progress
ever
use
molecular
biolog
genet
tool
viru
research
reveal
number
rather
curiou
fact
particular
ancestor
variola
viru
found
everyon
surpris
ancestor
monkeypox
viru
rather
cowpox
viru
accord
current
concept
viru
small
rodent
live
barn
cow
shed
evid
phylogenet
tree
repres
genu
orthopoxviru
fig
modifi
esposito
fenner
roman
numer
denot
differ
phylogenet
group
orthopoxvirus
variola
virus
cowpox
virus
iii
monkeypox
virus
iv
evid
natur
ancestor
smallpox
agent
abund
natur
po
sibil
evolutionari
transform
took
place
may
repeat
bring
viru
sim
ilar
pathogen
variola
virusmost
danger
human
popul
immun
exclud
thu
con
tinu
develop
new
better
vaccin
diseas
complet
justifi
fact
rather
threat
bioterror
anoth
curiou
fact
concurr
clari
fie
know
edward
jenner
vaccin
human
crust
ill
cow
sinc
notic
milk
maid
fall
ill
smallpox
howev
studi
genom
modern
vaccinia
virus
demonstr
closer
buffalopox
virus
rather
cowpox
viru
archiv
research
found
chines
hindu
centuri
use
rub
buffalopox
crust
human
skin
moreov
written
evid
retir
english
colonel
return
india
tri
intro
duce
england
fail
win
confid
english
sinc
physician
thu
current
vaccinia
viru
like
origin
buffalopox
viru
rather
cowpox
viru
although
jenner
possibl
use
latter
viru
mention
polioviru
also
stage
close
erad
current
viru
circu
late
fourfiv
countri
although
time
time
export
neighbor
countri
includ
russia
exampl
polioviru
export
afghanistan
uzbekistan
tajikistan
russia
case
diseas
mani
dose
polio
vaccin
much
medic
effort
necessari
prevent
spread
outbreak
also
concern
associ
ate
possibl
evolut
relat
virus
evid
phylogenet
tree
genu
enterovirus
fig
countri
use
live
polio
vaccin
coxsack
ieviru
morbid
slowli
increas
develop
countri
ceas
use
live
vaccin
like
increas
associ
fact
live
vaccin
longer
use
vaccin
wider
cessat
use
morbid
result
coxsackieviru
grow
note
enterovirus
rapidli
evolv
thu
cox
sackieviru
might
well
mutat
becom
less
pathogen
human
polioviru
vacci
nation
polioviru
stop
humankind
unprotect
diseas
thu
even
ce
sation
antismallpox
vaccin
justifi
hardli
reason
stop
vaccin
poliomi
eliti
sinc
relat
virus
may
evolv
caus
infec
tiou
diseas
infect
relat
drug
addict
upsurg
drug
addict
russia
enhanc
activ
spread
sever
infect
hiv
hepat
b
hepat
c
problem
worsen
use
nondispos
syring
result
turn
centuri
illustr
fig
exam
ple
hepat
c
rise
drug
addict
russia
determin
tens
moral
atmospher
countri
default
rapid
increas
drug
flow
afghanistan
almost
immedi
ate
american
troop
brought
afghani
stan
feder
drug
control
servic
russia
establish
fact
enhanc
drastic
decreas
drug
addict
countri
gradual
reduct
also
current
observ
due
first
effort
tajikistan
frontier
forc
well
russian
frontier
troop
custom
antidrug
ser
vice
focus
control
drug
flow
exam
ple
consider
larger
amount
drug
current
seiz
border
compar
addit
antidrug
inform
campaign
consid
erabl
intensifi
russia
although
level
anticip
base
sever
situat
drug
addict
russia
assay
viral
hepatitisposit
sampl
taken
infecti
hospit
novosibirsk
molecular
genet
method
dem
onstrat
preval
hcv
genotyp
older
age
cohort
versu
smaller
share
hcv
geno
type
compar
younger
age
cohort
fig
genotyp
histor
major
type
ru
sia
europ
north
asian
countri
genotyp
typic
near
east
particular
preval
afghanistan
fact
crude
drug
purif
like
includ
stage
sorb
impur
help
reject
donor
blood
prepar
afghanistan
infect
hcv
may
one
probabl
explan
research
team
publish
data
shustov
et
al
difficult
pass
review
intern
journal
without
provid
explan
sinc
data
look
unusu
note
analyz
popul
compris
individu
howev
analog
age
relat
pattern
hcv
genotyp
distribut
describ
paper
itali
unit
state
publish
later
almost
simultan
work
thu
emerg
infect
hcv
genotyp
associ
intraven
use
drug
come
afghanistan
data
report
start
assay
drug
sampl
virus
bioterror
act
except
known
case
letter
anthrax
spore
mail
wwwanthraxinvestig
com
current
threat
bioterror
regard
signific
natur
chief
bioterrorist
virolog
three
appli
field
develop
virolog
close
associ
advanc
molecular
biol
ogi
molecular
genet
virus
diagno
tic
viral
infect
treatment
viral
diseas
develop
vaccin
technolog
diagnost
viral
infect
tabl
list
main
method
use
earlier
use
mention
method
direct
microscop
exami
nation
almost
never
use
sinc
requir
high
concentr
least
particlesml
high
puriti
pathogen
infect
assay
plaqu
method
demonstr
research
deal
viru
fail
identifi
pathogen
igm
antibodi
detect
enzym
immunoassay
day
infec
tion
sever
symptom
respiratori
diseas
appear
earli
day
moreov
case
exampl
influenza
viru
viru
present
blood
day
thu
method
inappro
priat
common
viral
respiratori
gastrointesti
nal
diseas
detect
viral
antigen
enzym
immunoassay
passiv
hemagglutin
test
fea
sibl
short
time
span
viru
concen
age
year
genotyp
genotyp
genotyp
fig
share
hcv
genotyp
age
cohort
year
interv
accord
shustov
et
al
pp
tabl
comparison
quantit
assay
marker
pathogen
accord
egorov
et
al
assay
direct
count
electron
virus
light
bacteria
microscop
field
view
least
particlesml
high
concentr
purifi
patho
gen
necessari
plaqu
method
estim
infect
particlesml
assay
time
day
detect
igm
antibodi
elisa
possibl
earlier
day
infect
detect
antigen
elisa
pha
antigen
particlesml
pg
possibl
peak
infect
pcr
detect
genom
particlesml
sensit
high
potenti
lead
fals
posit
vol
tration
bodi
reach
maximum
day
viru
develop
bodi
case
acut
infect
clear
neg
test
result
mean
pathogen
absent
bodi
mean
concentr
pathogen
detect
threshold
thu
remain
polymeras
chain
reaction
pcr
assay
long
regard
doubt
due
high
rate
fals
posit
state
art
pcr
version
recogn
highli
reliabl
provid
sampl
process
reaction
mixtur
match
corr
spond
protocol
real
time
pcr
variant
even
applic
field
condit
give
rather
reli
abl
precis
result
main
yet
solvabl
current
problem
diagnost
tool
correct
select
pcr
primer
diagnost
kit
design
far
still
fail
detect
viru
genotyp
carri
substitut
region
complementari
primer
thu
genet
divers
virus
pathogen
human
studi
worldwid
particular
purpos
figur
schemat
replic
human
immunod
ficienc
viru
chose
viru
maxim
number
development
stage
among
rna
virus
exampl
allow
demon
strate
antivir
select
design
figur
show
stage
hiv
replic
white
label
denot
stage
replic
inhibitor
alreadi
develop
particular
inhibitor
genom
transcriptas
stage
genom
rna
transform
cdna
current
one
widespread
medic
hiv
note
inhibitor
nucleotid
nonnu
cleotid
natur
discov
use
inhibitor
frequent
use
togeth
sinc
virus
soon
develop
resist
one
drug
appli
second
white
label
denot
inhibitor
enzym
integras
insert
viral
rna
host
chromosom
inhibitor
may
also
either
nucl
otid
analog
nonnucleotid
natur
final
proteas
inhibitor
develop
third
label
use
togeth
first
two
drug
type
demonstr
integr
administr
inhibitor
daili
basi
abl
prolong
lifespan
hiv
infect
patient
year
black
label
fig
denot
stage
appro
priat
potenti
target
inhibitor
corr
spond
inhibitor
yet
design
one
possibl
test
research
design
recombin
antibodi
would
bind
hiv
cell
surfac
receptor
therebi
inhibit
attach
cell
howev
prepar
receiv
sever
hour
infect
believ
effect
tool
exampl
con
dom
nonetheless
antivir
undergo
ing
clinic
trial
sinc
still
vaccin
may
someon
dare
take
drug
tabl
consolid
data
vaccin
admini
tration
russia
last
year
compar
period
vaccin
correspond
diseas
exampl
annual
mor
biditi
measl
case
mortal
rate
reach
maximum
valu
children
age
year
current
measl
account
lethal
case
children
younger
one
year
countri
use
vaccin
measl
case
record
overal
russia
ie
approach
prev
alenc
rate
develop
countri
particular
unit
state
approxim
measl
case
record
import
statist
data
russia
wwwfcgsenru
wwwgksru
unit
state
wwwcdcgov
current
situat
mump
russia
slightli
wors
measl
howev
mass
vacci
nation
live
stabl
vaccin
commenc
two
decad
ago
given
impress
result
almost
complet
manag
control
poliomi
eliti
earli
poliomyel
case
record
popul
mainli
local
central
asian
countri
one
suspect
case
associ
que
tionabl
vaccin
diseas
import
russia
mention
howev
rapidli
elimin
ring
vaccin
nobel
prize
award
first
work
field
genet
engin
first
strain
produc
vaccin
hepat
b
also
construct
unit
state
clinic
trial
vaccin
start
alreadi
approv
phase
iii
clinic
trial
mass
stage
vaccin
becam
obligatori
newborn
unit
state
administr
russia
also
gave
good
result
morbid
russia
decreas
close
factor
ten
compar
factor
compar
today
morbid
level
hepat
b
russia
almost
develop
countri
unfortun
vaccin
base
control
rubella
russia
start
rather
recent
di
eas
could
still
elimin
russia
year
import
case
develop
coun
tri
use
vaccin
record
molecular
epidemiolog
molecular
epidemiolog
method
make
possibl
investig
case
human
viral
infect
well
detect
sourc
transmiss
chain
investig
mail
envelop
anthrax
bacilli
octob
envelop
contain
anthrax
bacilli
mail
unit
state
caus
five
death
us
govern
spent
mil
lion
dollar
prevent
spread
infect
post
sort
station
protect
contact
envelop
purpos
inform
pre
vention
station
organ
peopl
recommend
take
antibiot
day
molecular
epidemiolog
tool
use
charact
ize
specif
genet
featur
detect
anthrax
strain
allow
first
laboratori
strain
supposedli
taken
detect
particular
person
trace
inde
anthrax
agent
bacterium
rather
viru
yet
molecular
epidemiolog
analysi
sever
gene
sequenc
number
strain
identifi
refrig
ator
hous
mail
bacilli
limit
access
suppos
offend
detect
among
author
person
appear
psychiatr
deviat
wwwanthraxinvestigationcom
investig
mix
hcv
hiv
infect
case
case
woman
infect
partner
physician
investig
accord
ing
vogel
annual
medic
examin
show
infect
hcv
hiv
although
one
year
earlier
blood
test
show
infect
led
healthi
life
per
son
close
contact
partner
physician
background
inject
catarrh
diseas
suspect
genet
icist
sequenc
genom
isol
recov
sampl
compar
genom
sequenc
patient
never
contact
woman
sequenc
appear
ident
physician
got
long
sentenc
first
instanc
world
molecular
epidemiolog
tool
led
deserv
sentenc
guilti
person
approach
use
trace
epidemiolog
chain
transmiss
hiv
infect
well
stage
evolut
influenza
virus
becom
routin
approach
studi
ing
transmiss
pathway
virus
evolu
tion
thu
molecular
biolog
method
becom
appropri
tool
investig
crime
epid
miolog
chain
evolut
virus
sever
field
viru
applic
develop
diagnost
bacteri
diseas
bacteria
exampl
variou
salmonella
speci
rapidli
identifi
help
bacterioph
age
first
bacteria
sampl
plate
onto
nutrient
agar
coloni
grown
infect
specif
bacteriophag
presenc
target
bacterium
detect
accord
lysi
method
use
advent
enzym
immu
noassay
howev
almost
use
sinc
difficult
supplement
safe
maintain
nece
sari
set
specif
bacteriophag
schlegel
treatment
bacteri
diseas
highli
specif
bacteriophag
abl
rapidli
lyse
host
bacteria
earlier
approach
use
treat
diphth
ria
bacteriophag
appli
topic
difficulti
storag
bacteriophag
made
insuffici
pure
administ
human
current
approach
experienc
rebirth
use
strain
multipl
drug
resi
tanc
particular
method
could
promis
treatment
tuberculosi
control
insect
pest
highli
specif
ento
mopathogen
virus
densovirus
famili
parvovirida
baculovirus
discov
character
appli
control
mosquito
agricultur
insect
pest
still
rather
expens
ecolog
safe
due
extrem
specif
complet
safeti
mammal
mettenmey
ilinykh
control
undesir
anim
brought
australia
rabbit
becam
disast
due
rapid
reproduct
spread
limit
natur
enemi
combin
abund
feed
rab
bit
myxoma
viru
allow
method
control
abund
method
appli
success
move
one
australian
coast
ever
asynchron
use
enhanc
select
rabbit
race
resist
viru
question
thu
second
third
gener
virus
develop
control
rabbit
popul
http
wwwanimalcontrolcomaurabbithtm
live
inactiv
vaccin
effici
long
act
vaccin
live
vaccin
smallpox
measl
mump
rubella
poliomyel
exampl
inactiv
vaccin
influenza
hepat
tick
born
enceph
grammatiko
et
al
gene
therapi
adenovirus
aav
retroviru
vec
tor
other
use
treatment
genet
defect
howev
method
suspend
year
death
patient
rare
defect
immun
system
patient
rarest
specif
genet
featur
sen
sitiv
adenovirus
use
gene
therapi
marshal
therapi
cancer
diseas
virus
use
specif
lysi
defect
cancer
cell
research
conduct
russia
particular
state
research
center
virolog
biotechnolog
vec
tor
koltsovo
novosibirsk
oblast
russia
novosibirsk
state
univers
kochneva
et
al
long
ago
demonstr
virus
better
reproduc
cancer
cell
compar
normal
one
featur
boost
modifi
virus
addit
certain
gene
introduc
viru
genom
enhanc
apoptosi
cancer
cell
two
type
adenovirus
approv
clinic
administr
china
unit
state
phase
ii
clinic
trial
progress
verifi
viru
base
therapi
differ
cancer
type
accord
wwwclinicaltrialsgov
howev
problem
still
exist
sinc
virus
certain
famili
lyse
cancer
cell
specif
defect
determin
cancer
transform
defect
far
detect
tumor
type
virus
use
good
predict
find
mani
thing
genet
natur
cancer
know
virus
effi
cient
particular
cell
type
advanc
virolog
areassoci
follow
major
challeng
discoveri
infecti
agent
caus
diseas
earlier
consid
noninfecti
diabet
car
diovascular
diseas
cancer
becom
clearer
consider
number
diabet
case
result
rubella
infect
age
year
rearrang
immun
system
sever
hundr
case
describ
lit
eratur
clearli
suggest
pregnant
women
vaccin
rubella
also
children
age
year
common
practic
develop
countri
use
tripl
vac
cine
measl
mump
rubella
autom
improv
diag
nostic
technolog
develop
world
also
involv
acceler
simplif
diagnost
nearest
futur
exampl
would
possibl
onset
fever
place
finger
public
avail
exampl
supermarket
special
machin
hour
later
receiv
diagnosi
iden
tifi
pathogen
via
cell
phone
experiment
machin
alreadi
exist
avail
clinic
outpati
hospit
unit
state
develop
new
therapi
drug
viral
diseas
main
challeng
search
new
inhibitor
viru
enzym
effect
host
enzym
develop
new
effici
vaccin
note
still
vaccin
dan
gerou
widespread
diseas
hepat
c
hiv
infect
design
viru
base
tool
gene
therapi
cancer
treatment
viru
design
natur
ration
function
manner
reason
could
make
use
heal
prevent
variou
diseas
virus
danger
human
also
anim
exampl
chicken
industri
farm
vaccin
least
four
infect
specif
vaccin
eight
infect
avail
plant
among
best
known
exampl
viral
infect
plant
tulip
mosaic
viru
earli
begin
centuri
viru
natur
color
break
tulip
flower
postul
correspond
viru
name
tulip
mosaic
viru
viru
also
infect
speci
liliacea
famili
differ
degre
major
sign
denot
presenc
viru
tulip
chang
flower
color
becom
broken
result
impair
product
pigment
anthocyanin
color
flower
red
viru
also
danger
bulb
becom
smaller
give
ever
deform
flower
diseas
destroy
individu
specif
featur
cultivar
thu
ill
tulip
plant
found
bloom
reject
remov
tulip
mosaic
viru
transmit
thrip
whitefli
aphid
insect
critic
period
stabli
warm
weather
period
late
may
emerg
insect
therefor
recommend
time
detect
remov
infect
plant
diseas
spread
control
prevent
measur
still
unavail
interestingli
viru
also
found
garden
lili
infect
phenotyp
manifest
howev
suggest
tulip
rais
near
lili
sinc
may
destroy
tulip
cultivar
anoth
infer
plot
lili
grown
use
tulip
http
http
recent
sever
research
team
includ
author
paper
repeatedli
detect
import
dengu
fever
viru
western
siberia
includ
novosibirsk
tourist
south
asian
countri
past
year
case
detect
see
http
infect
spread
siberia
due
absenc
necessari
mosquito
speci
transmit
viru
one
pathogen
caus
enceph
west
nile
viru
also
current
detect
siberia
see
http
epid
predict
postul
increas
rate
fever
encephalitid
western
siberia
sinc
spread
european
russia
west
nile
viru
annual
caus
sever
hundr
case
unit
state
west
nile
fever
case
requir
hospit
annual
record
end
last
centuri
west
nile
viru
unknown
unit
state
spread
import
see
http
